Whether sunscreen use affects melanoma risk has been widely studied with contradictory results. To answer this question we performed a systematic review of all published studies, accounting for sources of heterogeneity and bias. We searched for original articles investigating the sunscreen-melanoma association in humans to February 28, 2018. We then used randomeffects meta-analysis to combine estimates of the association, stratified by study design. Stratified meta-analysis and metaregression were used to identify sources of heterogeneity. We included 21,069 melanoma cases from 28 studies published 1979-2018: 23 case-control (11 hospital-based, 12 population-based), 1 ecological, 3 cohort and 1 randomised controlled trial (RCT). There was marked heterogeneity across study designs and among case-control studies but adjustment for confounding by sun exposure, sunburns and phenotype systematically moved estimates toward decreased melanoma risk among sunscreen users. Ever-vs. never-use of sunscreen was inversely associated with melanoma in hospital-based casecontrol studies (adjusted odds ratio (OR) = 0.57, 95%confidence interval (CI) 0.37-0.87, p heterogeneity < 0.001), the ecological Key words: sunscreen, melanoma, skin cancer, meta-analysis, sun protection Abbreviations: CI: confidence interval; GRADE: grading of recommendations assessment, development and evaluation; HR: hazard ratio; N: Nord; NOS: Newcastle-Ottawa scale; OR: odds ratio; p: p Value; RCT: randomised controlled trial; RR: rate ratio; SE: summary estimate; SPF: sun protection factor; USA: United States of America; UV: ultraviolet Additional Supporting Information may be found in the online version of this article.
Introduction
Cutaneous melanoma is the leading cause of skin cancer death, 1 accounting for 1-2% of all cancer deaths. 2, 3 In 2015, melanoma occurred in 351,880 people and resulted in 59,782 deaths worldwide. 4 The aetiology of cutaneous melanoma (hereafter termed melanoma) is a complex interaction of genetic, epigenetic and environmental risk factors. 5, 6 Melanoma is mainly caused by ultraviolet (UV) radiation exposure in sun-sensitive subjects and it is estimated that more than 85% of melanoma cases in Europe are attributed to sun exposure. [7] [8] [9] [10] Genomic sequencing confirms that the majority of the mutations in melanomas are caused by UV radiation. 11, 12 It follows that melanoma is preventable through reduction of UV exposure, making primary prevention highly cost-effective. 10, 13 Use of sunscreen is generally regarded as a major primary prevention measure alongside seeking shade, wearing protective clothes, and avoiding sunbeds, [14] [15] [16] [17] and is a popular method of sun protection. 18 However effectiveness of sunscreen to reduce UV-induced damage to the skin has been proven only in experimental studies, 19 and evidence of its effectiveness in preventing melanoma in humans is inconclusive. Only one randomised controlled trial (RCT) of daily sunscreen application to prevent skin cancer has been performed, showing a reduced risk of melanoma (hazard ratio = 0.50, p value = 0.051) in those randomly assigned to daily compared to discretionary sunscreen use. 20, 21 The compliance to daily sunscreen application was approximately 75%; the majority of participants in the discretionary sunscreen group either did not apply sunscreen (38%) or applied at most once or twice a week (35%). 21 All other studies of sunscreen and melanoma risk have been observational, mainly case-control, yielding contradictory results. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] The main problem with investigating this question with observational studies is confounding by indication, i.e. sunscreen users tend to be more susceptible to melanoma and more exposed to the sun than non-users a priori. 41 The contradictory and heterogeneous results of previous systematic reviews reflect this problem. [42] [43] [44] [45] [46] [47] [48] In the current study we aimed to overcome these known limitations by performing in-depth statistical analyses, comparing different patterns of sunscreen use and identifying the major sources of heterogeneity. Furthermore we wanted to update the field with new evidence.
Specifically, we aimed to 1) systematically summarise the existing literature on sunscreen use and melanoma in humans; 2) investigate the effect of ever-vs. never-use on melanoma risk; 3) assess the effect of different levels and patterns of sunscreen use; 4) identify sources of bias and between-study heterogeneity; and 5) describe the relationship between site of sunscreen application and site of melanoma.
Methods
The study protocol of this systematic review (PROSPERO ID: CRD42017063980 49 ) was written according to PRISMA-P 50, 51 and the reporting in this article follows the PRISMA recommendations. 52 
Data sources and searches
We searched the electronic databases PubMed (including Medline), Embase and Cochrane Database of Systematic Reviews with search terms adapted for each of them (Supporting Information Appendix I). In addition, we searched the protocol database PROSPERO to identify relevant ongoing reviews and screen their reference lists. To ensure literature saturation we also screened the reference lists of relevant published reviews.
Study selection
We included all original articles published by 28.02.2018 in peer-reviewed journals arising from case-control studies, ecological studies (population-level rather than individual-level observational studies), cohort studies, intervention studies and clinical trials performed in humans with melanoma as endpoint and sunscreen use as exposure. We only included studies where the exposure clearly preceded the outcome. We had no restrictions regarding length of follow-up or language.
Studies on childhood melanoma were included in the qualitative synthesis but excluded from the meta-analyses because UV exposure does not seem to be a risk factor in the aetiology of melanoma occurring before 15 years of age. 53 All records from the literature research were imported into EndNote (Thomson Reuters, version X8), de-duplicated and then imported to Microsoft Excel (version 2010) to perform the selection process. Study selection was performed by two independent reviewers (CSR and JSS) by first screening titles and abstracts, then screening full texts. We calculated the proportion of agreement between the two reviewers for each of the two selection steps. Discrepancies were solved by discussion between the two reviewers. References were excluded based on the hierarchical exclusion criteria displayed in Figure 1 .
Data extraction and quality assessment
Data were extracted using a data extraction form 54 (Supporting Information Appendix II) after piloting the process with three studies of different design and publication year. Data extraction was performed by CSR and the estimates of interest were double-checked by MBV. Discrepancies were discussed among a subgroup of the authors until consensus was reached. We contacted study authors and requested the estimate of interest if it was not reported but the respective analysis was described. If necessary, additional articles from the same study were used to complete data extraction.
For each study we extracted the following estimates on the association of sunscreen use and melanoma, if reported: a) ever-vs. never-use of sunscreen from minimally adjusted model; b) ever-vs. never-use of sunscreen from maximally adjusted model; c) three-level estimate of sunscreen use from maximally adjusted models for frequency of use, sun protection factor (SPF) used and duration of use (Supporting Information Table 1 ). The minimally and maximally adjusted model was the model with no or only basic adjustment and the model with most variables included, respectively, in the original study. We chose the ever-vs. never-use label because most underlying studies analysed ever-vs. never-use or use vs. no use of sunscreen based on their questionnaires. In addition, we extracted bibliographic and demographic information of the studies, assessment of sunscreen use, and study quality to identify sources of heterogeneity. Study quality was assessed based on the Cochrane Handbook's tool for assessing risk of bias 54 and the Newcastle-Ottawa Scale (NOS). 55 Level of bias (high, medium, low) was rated by the data extractor (CSR) after reading the methods part of the study and blinded toward the study results.
Data synthesis and analysis
All analyses were performed in STATA (StataCorp LP, Release 14.1). In the analysis of ever-vs. never-use of sunscreen we used the method of Hamling and colleagues to aggregate estimates if more than two categories of sunscreen use were reported. 56 For example, if a study reported an estimate with three categories of sunscreen use: never, sometimes, and often, we aggregated 'sometimes' and 'often' into ever-use. This was done to make the estimates across studies more comparable. Without this aggregation we would end up pooling estimates across studies where some estimates reflected the effect of the highest sunscreen category vs. no sunscreen use, while others reflected ever-vs. never use. The same method was used to change the reference category, if necessary. To investigate three-level, different patterns and high sunscreen use, we extracted all estimates with at least three categories on frequency of sunscreen use, SPF used, and duration of use. For each study, the lowest and highest categories were categorised as lowest and highest groups, respectively and all intermediate categories were aggregated. 57 We performed random-effects meta-analysis 58 stratified by study design for the minimally and maximally adjusted estimates of ever-vs. never-use of sunscreen, and for each three-level variable on sunscreen use, comparing the intermediate to the lowest level and the highest to the lowest level. Heterogeneity between studies was tested with the Qtest. 59 The I 2 -index was used to quantify the extent of heterogeneity, with I 2 -values >50%, and > 75% being indicative of moderate and high heterogeneity, respectively. 54 We included one case-cohort study that was analysed together with the cohort studies because it was conducted prospectively.
To explore sources of heterogeneity we performed random-effects meta-analyses stratified by important variables predefined in the protocol, and univariable random-effects meta-regression analyses, on the maximally adjusted ever-vs. never-use estimate. We considered the following variables: study design; year of the end of the data collection (1975-1984, 1985-1999, 2000-2012) ; mean latitude (>42 N, ≤42 N); region; most frequent melanoma site in the study population (trunk, head/neck, lower limbs); duration of sunscreen use (not specified, specified period, lifetime); whether sunscreen use was assessed in detail or not; level of bias (high, medium, low); whether or not the estimate of interest was adjusted for nevi and/or freckles, history of sunburn, or sun exposure; and, the proportion of participants with blond/red hair (<30%, ≥30%), blue/green eyes (<50%, ≥50%), history of sunburn (<75%, ≥75%), and who never used sunscreen (<55%, ≥55%). The cut-offs in the proportions were chosen based on the distribution of the respective characteristic across the studies. We used tau-squared to estimate the remaining between-study variance in the meta-regression model by residual maximum likelihood. Publication bias was investigated by the funnel plot and Egger's regression test for the maximally-adjusted ever-never estimates. 60 We used contour-enhanced funnel plots to define regions of the plot in which a new study would have to be located to change the statistical significance of the metaanalysis and thereby assess the robustness of the current meta-analysis. 61 
Grading of the evidence
The confidence in the cumulative evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. 62 GRADE rates the quality of evidence across the domains risk of bias, consistency, directness, precision, and publication bias and rates it into one of the four categories high (further research is very unlikely to change our confidence in our effect estimate), moderate (further research is likely to change our confidence in our effect estimate), low (further research is very likely to change our effect estimate), or very low (our effect estimate is very uncertain).
Results

Study selection
We identified 3,414 records in the three databases Pubmed (n = 1,054), Embase (n = 2,132), and Cochrane (n = 228), of which 761 were duplicates and 2,552 were rated as ineligible on first screening by two reviewers (agreement = 95%; Fig. 1 ). Eleven studies were identified through other sources resulting in the assessment of 112 full-texts, of which 84 (agreement = 89%) were excluded, leaving 28 studies included in the qualitative synthesis and 27 studies in the meta-analysis after exclusion of the childhood melanoma study. 32 
Characteristics of included studies
The 28 articles (11 hospital-based case-control studies, 22, 23, 31, [33] [34] [35] 37, 39, [63] [64] [65] 12 population-based case-control studies, [24] [25] [26] [27] [28] [29] [30] 32, 36, 38, 40, 66 one ecological study, 67 three cohort studies (one of them a case-cohort study), [68] [69] [70] and one RCT 21 ) were published between 1979 and 2018, included 208 to 178,155 participants and 33 to 11,535 melanoma cases: in total, 21,069 melanoma cases, who originated from Australia (n = 4), Europe (n = 16), Brazil (n = 2) and the USA (n = 6; Table 1 ). The median latitude of the study locations was 43 N (range − 30 S-65 N). On average, 21% of participants (range 9-61%) were blond or red-haired, 47% (range 19-86%) blue or green eyed, 48% (range 28-70%) had freckles, and 55% (range 24-85%) were fair-skinned (Supporting Information Table 2 ). Most studies only assessed sunscreen use or sunscreen use frequency (Table 1) . Fourteen studies defined a timeframe for the sunscreen use, 21, 24, 25, 29, 32, 35, 36, 38, 40, 63, [65] [66] [67] [68] eight studies assessed the SPF used, 21, [35] [36] [37] 39, 40, 66, 69 three the reapplication, 40, 65, 66 three the body sites or body coverage, 21, 36, 40 two the product used, 35, 69 two the thickness, 21, 40 and one study the reasons for sunscreen use. 36 
Methodological quality of included studies
The methodological quality of the case-control studies was very heterogeneous with 11 hospital-based case-control studies based on non-representative cases and controls (Supporting Information Table 3 ). The ecological study, cohort studies and RCT fulfilled almost all of the methodological requirements.
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The method and detail of assessment of sunscreen use also varied greatly between the studies (Table 2) ; the same was true for the level of adjustment of the "maximally-adjusted" estimate, though most studies adjusted in some way for UV exposure and some host factors of participants.
Ever sunscreen use and melanoma risk
The forest plot of minimally-adjusted estimates showed substantial heterogeneity both within hospital-based (I 2 = 86%, p < 0.001) and population-based case-control studies (I 2 = 80%, p < 0.001), and between the different study designs (Fig. 2) .
The forest plot of maximally-adjusted estimates showed that adjustment moved most estimates toward a more reduced risk of melanoma among sunscreen users (Figs. 2 and 3) though substantial heterogeneity remained ( Fig. 3 ), especially within case-control studies (I 2 = 86%, p < 0.001 for hospitalbased; 81%, p < 0.001 for population-based) but also between study designs. We found an inverse sunscreen-melanoma association in hospital-based case-control studies (summary odds ratio (OR) = 0.57, 95%CI 0.37-0.87), the ecological study (rate ratio (RR) = 0.48, 95%CI 0.35-0.66), and the RCT (hazard ratio (HR) = 0.49, 95%CI 0.24-1.01). No association was found on summarising results from population-based casecontrol studies (OR = 1.17, 95%CI 0.90-1.51) and a positive sunscreen-melanoma association was seen on summarising the three cohort studies (HR = 1.27, 95%CI 1.07-1.51).
Three-level estimates of sunscreen use and melanoma risk
Sixteen studies reported at least a three-level estimate on the frequency of sunscreen use (never, sometimes, often/ always), 22, [24] [25] [26] [29] [30] [31] 33, 35, 36, 38, 40, 63, [68] [69] [70] six studies distinguished low from high SPF sunscreen use (compared to no use), [35] [36] [37] 40, 66, 69 and four studies distinguished short-from long-term use of sunscreen (compared to no use) 24, 25, 35, 36 (Supporting Information Table 4 ). We did not observe a trend or U-shaped association comparing the intermediate-and high-users of sunscreen to the non-users for each of the threelevel estimates (Supporting Information Fig. 1 ). The summary estimates comparing sometimes-to never-use were 1.07 (95% CI 0.80-1.42) in the hospital-based case-control studies, 1.13 (95%CI 0.98-1.30) in the population-based case-control studies, and 1.38 (95%CI 1.17-1Á62) in the cohort studies. The summary estimates comparing often/always-to never-use were 1.01 (95%CI 0.38-2.67) in the hospital-based casecontrol studies, 1.01 (95%CI 0.67-1.52) in the populationbased case-control studies, and 1.32 (95%CI 1.10-1.59) in the cohort studies (Supporting Information Fig. 1A ). This column gives an overview of the sunscreen information assessed in the study. The detailed descriptions of the sunscreen estimates used in the meta-analyses are given in Table 2 and Supporting Information Table 4. 3 Sunscreen and melanoma in childhood. 4 Sunscreen and melanoma in adolescence. 5 Data received upon author request with some differences to the article cited. 6 Case-cohort study design. 
Sources of heterogeneity
The association between sunscreen use and melanoma from stratified analyses is presented in Table 3 and Supporting Information Figure 2 . Studies conducted in lower latitudes showed an inverse association between sunscreen use and melanoma (summary estimate = 0.64, 95%CI 0.47-0.89 for studies ≤42 N) but there was no association in studies from higher latitudes (summary estimate = 1.09, 95%CI 0.83-1.44, p interaction = 0Á042). Further statistically significant interactions were observed between the association of sunscreen use and 1) the region of the study (p interaction = 0.008); 2) adjustment for nevi and/or freckles (with an inverse association only in studies adjusting; p interaction = 0.035); and, 3) the proportion of sunscreen users in the study (with an inverse association of sunscreen use and melanoma only in studies where ≥55% of participants never used sunscreen; p interaction = 0.012). Remaining between-study variance was generally high after all stratifications (0.131 ≤ tau-squared ≤ 0.492).
Site of sunscreen application and site of melanoma
Two studies 21, 36 assessed the body site of sunscreen application but neither related this to the site of melanoma.
Meta bias and quality of the cumulative evidence
The funnel plot (Supporting Information Fig. 3) shows the effect estimates from the individual studies against the precision of the studies (standard error in reversed scale), placing the largest studies toward the top. In the absence of bias and between-study heterogeneity, the plot would have resembled a symmetric inverted funnel, while our plot showed evidence of asymmetry confirmed by an Egger's test for small-study effects (p = 0.010). The funnel plot with contours of statistical significance (Supporting Information Fig. 4) shows which combinations of effect size and standard error would be required in an additional study, to change or maintain the statistical significance of the current summary estimate. In our meta-analysis, the plot showed that all of the current studies were lying in the area where future studies (if lying in the same area) would change the current effect estimate toward a significantly positive association between sunscreen use and melanoma risk (significant effect estimate >1).
The GRADE assessment resulted in an overall very low quality of evidence from the case-control studies, ecological study and cohort studies, and in a moderate quality of evidence from the RCT (Supporting Information Table 5 ).
Discussion
We assessed the sunscreen-melanoma association in 21,068 melanoma patients based on 28 studies in this comprehensive systematic review. The main body of evidence came from observational studies with high between-study heterogeneity. We found an inverse association between sunscreen use and melanoma in hospital-based case-control studies, the ecological study and the RCT. There was no association in the population-based casecontrol studies and positive association between sunscreen use If sunscreen exposure was reported in more than two categories they were aggregated into two categories (evervs. never-use).
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As reported by the authors. 3 Estimate from individual-matched case-control study that did not take the matching into account in the statistical analysis, or did not report it. 4 Estimate from frequency-matched case-control study that did not adjust for the matching variables in the statistical analysis, or did not report it. 5 Sunscreen and melanoma in childhood. 6 Sunscreen and melanoma in adolescence. 7 Estimates received upon author request because they were not reported in the cited article. 8 Case-cohort study design.
and melanoma in the cohort studies. No clear pattern resulted when comparing the few studies that reported three-level estimates of sunscreen use regarding frequency of use, SPF of sunscreen used or duration of use. The association between sunscreen use and melanoma differed by latitude, region, adjustment for nevi/freckling, and proportion of never sunscreen users.
Comparison with previous meta-analyses
Our study is the first systematic review and meta-analysis to present results from four different study designs, the first to include five prospective studies, and the first to stratify the case-control studies into hospital-based and population-based studies. , 2015 46 , and 2018 48 ). Only Dennis and colleagues (2003) 44 aggregated threelevel estimates of sunscreen use into ever-vs. never-use, as we did, but the final estimate (pooled OR = 1.0, 95%CI 0.8-1.2, from 18 case-control studies) was unadjusted for confounding factors. Consistent with our findings, they showed that adjustment moved estimates toward a reduced risk of melanoma in sunscreen users, by pooling only the nine studies that adjusted for sun sensitivity (OR = 0.8, 95%CI 0.6-1.0). 44 Similar to our approach, Dennis and colleagues tried to go beyond "ever-use" of sunscreen and pooled 12 case-control studies that reported at least a three-level estimate on the frequency of sunscreen use (aggregated by ordered regression models) but found no association. 44 Despite high heterogeneity, the other four meta-analyses pooled results using quite different definitions of sunscreen use into one estimate (for example always-vs. never-use and evervs. never-use), across very different study designs or different types of skin cancer, and across estimates from adjusted and unadjusted models. The earliest meta-analysis (2002) 43 included Figure 2 . Forest plot for ever-vs. never-use of sunscreen and melanoma risk, minimally adjusted estimates stratified by study design. The figure shows the forest plot for melanoma risk comparing ever-vs. never-use of sunscreen for all studies that reported a minimally adjusted estimate, stratified by study design. The estimates of the case-control studies are reported in odds ratios with 95% confidence intervals (CIs); and, the estimates of the cohort studies and the RCT as hazard ratios with 95% CIs. Minimal adjustment of some estimates (e.g. age and sex) and exact definition of the estimates is described in Table 2 . Abbreviations: CI, confidence interval; ES, effect size; RCT, randomised controlled trial. * Not ever-vs. never-use of sunscreen; see Table 2 for the exact definition of the estimate. **Case-cohort study. [Color figure can be viewed at wileyonlinelibrary.com]
11 case-control studies but pooled only the four registry-based, resulting in no association (OR = 1.01). Gorham and colleagues (2007) 45 included 17 case-control studies with a pooled OR = 1.2 (95%CI 0.9-1.6). Similar to our review, they found statistically significant interaction with study latitude. Xie and colleagues (2015) 46 included 21 studies and calculated a summary estimate of 1.15 (95%CI 0.91-1.44; I 2 = 84%, p heterogeneity < 0.001). This review 46 also tried to identify sources of heterogeneity by metaregression but found no significant interactions. The most recent meta-analysis (2018) 48 included 30 studies but only 25 were related to melanoma. They included only two prospective studies compared to five in our review, included cross-sectional study designs and calculated a summary estimate despite high heterogeneity (summary estimate = 1.08, 95%CI 0.91-1.29, including melanoma and other skin cancers). It is not possible to directly compare the aggregated estimates of association from these previous meta-analyses with our sorted and stratified estimates.
Interpretation of results
When interpreting our results, we needed to account for the different levels of evidence of the study designs included in our meta-analyses. In the hierarchy of strength of evidence, ecological studies are the weakest, and cohort studies and RCTs are the strongest. 71 Our funnel plot showed small-study effects, meaning that the results in small studies differed from the results in large studies. We suspect that this funnel plot asymmetry is due to poor methodological quality in small studies rather than publication bias. 60 This supports the fact that our results need to be interpreted taking the methodological quality and level of evidence into account as was done in the GRADE assessment. Forest plot for ever-vs. never-use of sunscreen and melanoma risk, maximally adjusted estimates stratified by study design. The figure shows the forest plot for melanoma risk comparing ever-vs. never-use of sunscreen for all studies that reported a maximally adjusted estimate, stratified by study design. The estimates of the case-control studies are reported as odds ratios with 95% confidence intervals (CIs); the estimates of the cohort studies and the RCT as hazard ratios with 95% CIs; and, the estimate of the ecological study as rate ratio with 95% CI. Adjustment and exact definition of the estimates is described in Table 2 . Abbreviations: CI, confidence interval; ES, effect size; RCT, randomised controlled trial. *Not ever-vs. never-use of sunscreen; see Table 2 for the exact definition of the estimate. **Case-cohort study. [Color figure can be viewed at wileyonlinelibrary.com] Careful interpretation of the results of the observational studies is essential because of their multiple methodological limitations when assessing the sunscreen-melanoma association: recall bias (in the case-control studies); ecological fallacy (in the ecological study, where we do not know whether the specific individuals who used sunscreen were those with lower incidence of melanoma because the association was measured at the population level); difficulty in meaningfully assessing sunscreen use by ad hoc questionnaires; and, by far the most concerning, residual confounding since the determinants of sunscreen use and melanoma (susceptibility to sunburn and high sun exposure) are almost inseparable in observational studies. 41 Furthermore, in their large population-based cohort study, 69 Ghiasvand and colleagues found significant differences between sunscreen users and non-users in regard to phenotype and sun exposure. Our review highlights the profound influence of residual confounding by showing that increasing adjustment systematically moved effect estimates toward a more reduced risk of melanoma among sunscreen users. The problems incorporated in observational studies have also led to an overall very low quality of evidence in the GRADE rating. 72 To overcome this problem we suggest performing cohort studies that also explore reasons for sunscreen use and non-use, and how sunscreen users' behaviour differs from that of non-users, 73 or analysing cohort studies using newer statistical methods (for example inverse probability weighting of using sunscreen) that can adjust for confounding by indication and mimic an RCT design. 74 In observational studies, "treatment selection" (sunscreen use in our case) is often influenced by subject characteristics. As a result, baseline characteristics of subjects using sunscreen differ systematically from those not using sunscreen. A propensity score such as inverse probability weights is the probability of using sunscreen conditional on observed baseline characteristics. Applying such weights allows one to analyse an observational (nonrandomized) study so that it mimics an RCT by balancing the distribution of observed baseline covariates between sunscreen users and non-users. 75 The strongest existing evidence comes from the one RCT, as suggested by the pyramid of evidence. 76 The RCT was performed in an Australian population with high year-round sun exposure and skin cancer awareness. 21, 77 There is therefore a need for additional high-quality, large RCTs in countries of higher latitude, but these are highly unlikely to be conducted because of ethical constraints (vulnerable study participants cannot be denied regular use of sunscreen) and the need to enrol extremely large numbers of participants in order to prospectively assess the rare outcome of melanoma. 19 However, future RCTs could examine intermediate endpoints (biomarkers, genetic mutations) to improve the evidence-base for sunscreen use. 19 Because of the imprecise definition of ever-vs. never-use of sunscreen and highly variable assessment of sunscreen use across studies, we compared the studies reporting at least three-levels and different patterns of sunscreen use. Unfortunately very few studies reported such estimates, and therefore we could not provide evidence about what pattern of use would be most effective and whether there is a discernible trend with increasing frequency of sunscreen use. We generally observed that very few studies assessed sunscreen use behaviour in depth such as exploring thickness of sunscreen applied, re-application or proportion of body covered with sunscreen. Such information would be crucial to assess in future research in relation to melanoma risk since we know that most people do not apply sunscreen properly. 78, 79 Of further concern is the high heterogeneity between studies that could not be fully explained by the variables we investigated in the meta-regression analysis (see also heterogeneity between study participants in Supporting Information Table 2 ). We found a more protective effect of sunscreens in lower latitudes and Southern countries. This might be due to sun exposure being more Remaining between-study variance estimated by residual maximum likelihood. 4 p Value for trend.
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A few studies included rare sunscreen users in the "never user" category. See Table 2 for the exact definition of the sunscreen variable.
homogeneous in these studies (everybody is exposed to some degree) and to sunscreen use being regarded as a routine preventive measure rather than being regarded as a means to prolong sun exposure by some at higher latitudes. 80, 81 It would therefore be important to distinguish between studies where sunscreen was used for intentional sun exposure and tan acquisition versus for protection from sun damage. This was not possible with currently available evidence. Also, people from lower and higher latitude might differ in their interpretation of frequencies of sunscreen use. For example higher latitude participants might consider "often" using sunscreen means applying on sunny days, whereas lower latitude participants may think of "often" using sunscreen as daily application.
We further found an inverse association between sunscreen use and melanoma in studies where the estimate was adjusted for number of naevi and/or freckling, while no association was found in studies without such adjustment. This might be due to the fact that number of naevi/freckling are especially important predictors of melanoma, 82 and self-reported assessment of number of naevi/ freckling as confounding factor might be more valid than other factors (e.g. sun exposure or sunburns long time ago). 83, 84 We found an inverse association of sunscreen use and melanoma in studies with a high proportion of never sunscreen users. This makes sense because of a better contrast between sunscreen users and non-users, revealing the effect of sunscreen in populations where the majority is not using it.
Strengths and limitations
This systematic review has several strengths. Compared to previous reviews, it adds several new studies and study designs, including three large cohort studies, and performs in-depth statistical analyses. We have extracted a variety of descriptive variables to identify sources of heterogeneity. To make the sunscreen variable as comparable as possible between studies, we attempted to aggregate or transform the estimates into ever-vs. never-use of sunscreen in order to combine the studies, but this inherited the weakness that the sunscreen measure was very broad, further obscuring any true effect of sunscreen.
Other limitations include the relatively low number of eligible studies, especially intervention studies and studies reporting threelevel estimates on sunscreen use, the difference in study designs, and the between-study heterogeneity. Because of the high heterogeneity we could not calculate an overall summary estimate. Due to the limited number of studies we could not perform multivariable meta-regression analysis, and were forced to collapse the metaregression and stratified meta-analysis over the different study designs. Also, we could not identify enough studies to answer our last research question on a possible relationship between body sites of sunscreen application and of melanoma. Furthermore, we used the label ever-vs. never-use because never or no use were the terms mostly used in the original studies included in the meta-analysis. This might be somewhat misleading as the never-users probably include some who used sunscreen rarely.
Conclusion
We found overall weak and heterogeneous published evidence for an association between sunscreen use and melanoma. Observational studies showed an inverse association in hospital-based case-control studies and the ecological study, no association in population-based case-control studies and a positive association in the three cohort studies. A protective effect of sunscreen was found in the only RCT performed. We therefore advocate for studies examining intermediate (biological) endpoints to be used in highquality RCTs. The effectiveness of sunscreen to reduce UV radiation to the skin has been proven after acute exposure in human studies and in experimental studies. 19 In our review, this translated into a reduced melanoma risk in the long-term for only some studies and we attribute this to residual confounding of observational studies and the misuse of sunscreen to increase rather than decrease sun exposure in some high latitude populations. Public health recommendations should place greater emphasis on the proper use of sunscreen (for sun protection vs. to prolong time in the sun) in conjunction with other means of sun protection.
